FVIII/VWF ratio is not a reliable predictor of VWD in children.

about

Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice.

P2860

Q42373755-7CE0663F-1442-4C7D-9D6F-182AFE67ED61

P2860

FVIII/VWF ratio is not a reliable predictor of VWD in children.

Item

http://www.wikidata.org/entity/Q54528863

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@en

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@nl

type

Item

label

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@en

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@nl

prefLabel

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@en

FVIII/VWF ratio is not a reliable predictor of VWD in children.

@nl

P1476

FVIII/VWF ratio is not a reliable predictor of VWD in children

@en

P2093

Elizabeth Villalobos-Menuey

http://www.w3.org/2001/XMLSchema#string

Jorge A Di Paola

http://www.w3.org/2001/XMLSchema#string

Katherine Ruegg

http://www.w3.org/2001/XMLSchema#string

Linda J Jacobson

http://www.w3.org/2001/XMLSchema#string

Marilyn Manco-Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP

Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo.

Functional architecture of Weibel-Palade bodies.

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

Preanalytical conditions that affect coagulation testing, including hormonal status and therapy.

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

The coagulation system in children: developmental and pathophysiological considerations.

Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.

P304

936-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24860

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian R Branchford

P577

2013-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24281894

http://www.w3.org/2001/XMLSchema#string

FVIII/VWF ratio is not a reliable predictor of VWD in children.

about

P2860

P2860

FVIII/VWF ratio is not a reliable predictor of VWD in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698